Dermapharm Holding SE buy thorstenm
Start price
12.01.23
/
80%
€39.44
Target price
12.01.26
€60.00
Performance (%)
-6.19%
Price
24.05.24
€37.00
Summary
This prediction is currently active. With a performance of -6.19%, the BUY prediction by thorstenm is trending in the wrong direction. This prediction currently runs until 12.01.26. The prediction end date can be changed by thorstenm at any time. thorstenm has 80% into this predictionDermapharm Holding is a Munich-based pharmaceutical company that develops innovative drug formulations and medical devices. It is listed on the Frankfurt Stock Exchange and has a strong presence in Germany and Europe. The company's product portfolio includes preparations for both prescription and over-the-counter drugs, as well as medical devices used in dermatology and urology. Dermapharm Holding differentiates itself from competitors by focusing on niche markets and developing new products in-house through its research and development activities.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Dermapharm Holding SE | -1.070% | -1.070% | -19.073% |
| iShares Core DAX® | -0.205% | 2.949% | 17.330% |
| iShares Nasdaq 100 | 1.613% | 5.877% | 37.451% |
| iShares Nikkei 225® | -0.740% | -1.256% | 11.847% |
| iShares S&P 500 | 0.267% | 3.240% | 29.308% |